U.S. Markets closed

Varian Medical price target lowered to $64 from $70 at Cantor

Cantor reduced its target on Varian after the company provided weaker than expected guidance. The firm expects the macro and regulatory challenges facing the company to persist and it keeps a Hold rating on the shares.